Browse the full record of transactions filed by 김지환, Executive. Director active across 2 companies, notably 케이엠제약. Cumulatively, 45 disclosures have been logged. Activity tracked since 11 March 2026. The latest transaction was disclosed on 21 April 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Declarations 45 total
● Executives · 1 Jun 2026 (filed)
● Executives · 1 Jun 2026 (filed)
● Executives · 21 Apr 2026 (filed) · 케이엠제약 11,300 shares DART:20260421000240 Ideal exit: 16 Jan 2027 (T+270) ● 상무이사 · Executives · 13 Apr 2026 · 케이엠제약 1,300 shares @ ₩535.0692 0.0000% mcap 100.0% of flow Share DART:20260420000241 Ideal exit: 8 Jan 2027 (T+270) ● Executives · 9 Apr 2026 (filed) · 케이엠제약 23,711 shares DART:20260409002021 Ideal exit: 4 Jan 2027 (T+270) ● 회장 · Executives · 25 Mar 2026 · 케이엠제약 600 shares @ ₩465.00 0.0000% mcap 1.8% of flow Share DART:20260409001985 Ideal exit: 20 Dec 2026 (T+270) ● 대표이사 · Executives · 17 Mar 2026 · 케이엠제약 26,863 shares @ ₩410.0109 0.0000% mcap 100.0% of flow Share DART:20260324000665 Ideal exit: 12 Dec 2026 (T+270) ● Executives · 24 Mar 2026 (filed) · 케이엠제약 26,863 shares DART:20260324000881 Ideal exit: 19 Dec 2026 (T+270) ● Executives · 23 Mar 2026 (filed)
● 대표이사 · Executives · 6 Mar 2026 · 케이엠제약 38,485 shares @ ₩391.2617 0.0001% mcap 98.2% of flow Share DART:20260311003196 Ideal exit: 1 Dec 2026 (T+270) ● Executives · 11 Mar 2026 (filed) · 케이엠제약 38,485 shares DART:20260311003218 Ideal exit: 6 Dec 2026 (T+270) ● Executives · 3 Mar 2026 (filed) · 케이엠제약 24,821 shares DART:20260303001597 Ideal exit: 28 Nov 2026 (T+270) ● 대표이사 · Executives · 3 Mar 2026 (filed) · 케이엠제약 24,821 shares Share DART:20260303001554 Ideal exit: 28 Nov 2026 (T+270) ● Executives · 9 Feb 2026 (filed) · 케이엠제약 5,600 shares DART:20260209000516 Ideal exit: 6 Nov 2026 (T+270) ● 상무이사 · Executives · 2 Feb 2026 (filed) · 케이엠제약 Share DART:20260202000162 Ideal exit: 30 Oct 2026 (T+270) ● Executives · 2 Feb 2026 (filed) · 케이엠제약 6,773 shares DART:20260202000282 Ideal exit: 30 Oct 2026 (T+270) ● Executives · 12 Jan 2026 (filed) · 케이엠제약 ● Executives · 8 Dec 2025 (filed) · 케이엠제약 ● Executives · 8 Jul 2025 (filed)
● Executives · 8 Apr 2025 (filed)
● Executives · 6 Jan 2025 (filed)
● Executives · 6 Dec 2024 (filed) · 케이엠제약 ● Executives · 8 Oct 2024 (filed) · 케이엠제약 ● Executives · 10 Jul 2024 (filed) · 케이엠제약 ● Executives · 1 Jul 2024 (filed) · 케이엠제약 25 of 45 declarations
Load more (20 remaining) About 김지환 Kim Ji-hwan is an executive at KM Pharmaceutical, a company active in the pharmaceutical sector. He contributes to the strategic management of the company and process optimization. His role is essential in ensuring KM Pharmaceutical's competitiveness in the market.